New EnglandPop. 647K

GLP-1 Coverage & Costs in Vermont (2026)

$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Vermont at intake.

The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.

Medicaid: not covered as of January 2026 (KFF)
Eduard Cristea
Eduard Cristea
Published: |Updated:

Vermont Medicaid Coverage for GLP-1

Medicaid: not covered as of January 2026 (KFF)

KFF's map lists Vermont as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.

Your Options in Vermont:

  • Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Vermont
  • Commercial or employer insurance: check your plan's drug list and prior authorization rules
  • Medicare GLP-1 Bridge for eligible Part D enrollees (see below)

Vermont Medicaid GLP-1 Prescriptions in 2025

Prescriptions paid

17,163

Rank of 51

#48

Medicaid paid, before rebates

$18.5 million

Most-filled product

Ozempic

Vermont Medicaid paid for 17,163 GLP-1 prescriptions in 2025, 0.2% of the 11.26 million paid nationally and number 48 of 51 (50 states and DC). It reimbursed pharmacies $18.5 million before manufacturer rebates, about $1,077 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 1,200 of those prescriptions (7%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.

From 2021 to 2025, Vermont Medicaid GLP-1 prescriptions went from 7,845 to 17,163, 2.2 times the 2021 count. From 2024 to 2025 the count rose by 3,007.

2021

7,845

2022

11,273

2023

14,233

2024

14,156

2025

17,163

ProductVT Medicaid prescriptions, 2025Share
Ozempic7,81345.5%
Trulicity5,76233.6%
Mounjaro1,72410%
Zepbound1,0596.2%
Rybelsus4392.6%
Victoza2251.3%
Wegovy1410.8%

Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.

Vermont Employee Plan and Insurer GLP-1 Rules

We have not read the Vermontstate employee health plan's own documents, so we do not state whether it covers GLP-1s for weight loss. State employees can ask their benefits office or check the plan's drug list.

We have no Vermontinsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.

Comparing self-pay programs in Vermont?

2-minute quiz: filter by budget and medication preference.

Take the quiz →

Telehealth Programs to Check for Vermont

We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Vermont. The rest record a state count without naming the states, so confirm Vermont with the program at intake before you pay.

What Programs' Own Pages Say About Vermont

8 of the 8 programs whose own pages name the states they serve include Vermont: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.

Trimi's state table lists Vermont as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Vermont is 18 V.S.A. § 9361(b). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.

Programs on Our List, in Published Order

Compounded GLP-1 care with one-month and prepaid plans

Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support

Affordable compounded semaglutide from $119/mo with free shipping and health coaching

From $119/mo semaglutide, from $185/mo tirzepatide, 12-month planCompounded Semaglutide, Compounded TirzepatideAll 50 States

Personalized GLP-1 weight loss with licensed providers and nationwide coverage

45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.

Estimated GLP-1 Costs in Vermont

Best Value

Telehealth (Compounded)

$79 to $399/mo

Recorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.

Wegovy

Brand prices with and without insurance.

Zepbound

List, LillyDirect and savings card prices.

No insurance

Self-pay GLP-1 options without coverage.

The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.

Medicare Part D GLP-1 Claims in Vermont, 2024

Vermont prescribers wrote 41,065 Medicare Part D GLP-1 claims in 2024, number 48 of 51, with $50.1 million in gross drug cost before rebates. Ozempic led with 20,117 claims for 3,802 enrollees. Wegovy had 582 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.

ProductVT Part D claimsEnrollees
Ozempic20,1173,802
Trulicity11,1331,966
Mounjaro5,5281,038
Rybelsus2,394572
Victoza695Not given
Wegovy582141
Bydureon Bcise42894
Liraglutide16456
Byetta24Not given

Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.

Now Live — Launched July 1, 2026

Medicare GLP-1 Bridge Program in Vermont

The Bridge is national, so the rules are the same in Vermont as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.

Patient Cost

$50/mo

Launch Date

July 1, 2026

Runs Through

Dec 31, 2027

Read the Full Medicare Guide

How Vermont Compares to Other New England States

Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Vermont and its neighbors in the New England are recorded:

StateMedicaid and GLP-1s for obesityMedicaid GLP-1 Rx, 2025
Vermont (this page)Not covered17,163
MaineNot covered41,655
New HampshireNot covered34,652
Rhode IslandNot established46,691

Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.

KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.

If Your Insurance Denies GLP-1 Coverage in Vermont

Commercial plans offer an internal appeal, then external review; Vermont Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.

How to Check Your Specific Plan in Vermont

  • Vermont Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
  • State employees: we have not read the plan's documents; ask the benefits office.
  • Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.

Find the Right GLP-1 Provider in Vermont

Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Vermont.

Frequently Asked Questions — Vermont

Does Vermont Medicaid cover GLP-1 medications for weight loss?
KFF's map lists Vermont as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. You can also look at telehealth programs (recorded monthly-plan prices from $79/month; confirm Vermont at intake), commercial insurance, or the Medicare GLP-1 Bridge.
How many GLP-1 prescriptions did Vermont Medicaid pay for in 2025?
Vermont Medicaid paid for 17,163 GLP-1 prescriptions in 2025, 0.2% of the 11.26 million paid nationally and number 48 of 51 (50 states and DC). It reimbursed pharmacies $18.5 million before manufacturer rebates, about $1,077 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 1,200 of those prescriptions (7%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it. From 2021 to 2025, Vermont Medicaid GLP-1 prescriptions went from 7,845 to 17,163, 2.2 times the 2021 count. From 2024 to 2025 the count rose by 3,007. Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026).
How many Medicare Part D GLP-1 claims were there in Vermont in 2024?
Vermont prescribers wrote 41,065 Medicare Part D GLP-1 claims in 2024, number 48 of 51, with $50.1 million in gross drug cost before rebates. Ozempic led with 20,117 claims for 3,802 enrollees. Wegovy had 582 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses. Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026).
What is the cheapest way to get GLP-1 medication in Vermont?
The lowest monthly-plan price we have recorded among programs on this page is $79/month (Embody, compounded semaglutide, monthly plan). Embody lists 48 states and our records do not name them, so confirm Vermont at intake. Medicare Part D enrollees who qualify can get Foundayo, Wegovy or Zepbound KwikPen for $50/month through the Bridge.
Which online GLP-1 programs serve Vermont?
8 of the 8 programs whose own pages name the states they serve include Vermont: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. For the other programs on this page, confirm Vermont at intake before you pay.
Does Medicare cover GLP-1s in Vermont?
Yes for eligible Part D enrollees in Vermont: $50/month through the Medicare GLP-1 Bridge, July 1, 2026 to December 31, 2027, under the BMI rules in the Medicare section above.

Ready to start?

Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody